Replimune (REPL) Total Current Liabilities (2018 - 2026)

Replimune (REPL) reported Total Current Liabilities of $58.2 million for Q1 2026, down 6.63% on a YoY basis from $62.4 million in Q1 2025, and up 16.25% sequentially from $50.1 million in Q4 2025.

Replimune (REPL) Total Current Liabilities (2018 - 2026) Analysis & Trends

Replimune (REPL) has 9 years of Total Current Liabilities data on file, last reported at $58.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities fell 6.63% year-over-year to $58.2 million; the trailing twelve-month figure through Mar 2026 stood at $58.2 million (down 6.63% YoY), and the FY2026 full-year result was $58.2 million, down 6.63% from the prior year.
  • Total Current Liabilities improved to $58.2 million in Q1 2026, from $50.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $62.4 million in Q1 2025 to a low of $20.3 million in Q2 2022.
  • A 5-year average of $40.4 million and a median of $39.8 million in 2023 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities soared 69.23% in 2023 and retreated 6.63% in 2026, its largest moves.
  • Tracing REPL's Total Current Liabilities over 5 years: stood at $26.5 million in 2022, then soared by 46.05% to $38.6 million in 2023, then rose by 23.91% to $47.9 million in 2024, then advanced by 4.59% to $50.1 million in 2025, then climbed by 16.25% to $58.2 million in 2026.
  • Business Quant data shows REPL's Total Current Liabilities at $58.2 million in Q1 2026, $50.1 million in Q4 2025, and $52.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Replimune 970.73 Mn 970.73 Mn - 58.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 58.23 Mn
Dec 31, 2025 50.09 Mn
Sep 30, 2025 52.90 Mn
Jun 30, 2025 59.56 Mn
Mar 31, 2025 62.36 Mn
Dec 31, 2024 47.89 Mn
Sep 30, 2024 43.79 Mn
Jun 30, 2024 35.68 Mn
Mar 31, 2024 40.44 Mn
Dec 31, 2023 38.65 Mn
Sep 30, 2023 39.83 Mn
Jun 30, 2023 32.24 Mn
Mar 31, 2023 33.83 Mn
Dec 31, 2022 26.46 Mn
Sep 30, 2022 23.54 Mn
Jun 30, 2022 20.31 Mn
Mar 31, 2022 20.76 Mn
Dec 31, 2021 18.29 Mn
Sep 30, 2021 16.64 Mn
Jun 30, 2021 15.05 Mn